DXCM

DexCom, Inc. · NASDAQ · Healthcare · USD · 10-K for 2025, filed 2026-02-12

Figures on this page computed 2026-11-08 13:05 UTC

Last close

88.48USD

Market data, 2026-11-04

DXCM: weekly closes from 89.75 on 2026-08-14 to 88.48 on 2026-11-04, a move of -1.4%. Prices in USD.

Weekly closes, 2026-08-14 to 2026-11-04

Over that span: -1.4%

Except where said otherwise: 10-K for 2025, filed 2026-02-12

37.1xP/E
Price / Earnings per Share (diluted)
Source
computed
Fiscal year
2025
Accession
0001093557-26-000027
Reported in
USD
- computed
- 10-K for 2025, filed 2026-02-12
The filing itself
n/aROIC
We do not hold this figure for this company, so there is nothing to place.
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
Source
computed
Fiscal year
2025
Accession
0001093557-26-000027
Reported in
USD
- 10-K for 2025, filed 2026-02-12
- 10-K for 2025, filed 2026-02-12
- 10-K for 2025, filed 2026-02-12
- 10-Q for 2025, filed 2026-10-29
- 10-K for 2025, filed 2026-02-12
- 10-Q for 2025, filed 2026-10-29
The filing itself
17.9%Net margin
Net Income / Revenue x 100
Source
computed
Fiscal year
2025
Accession
0001093557-26-000027
Reported in
USD
- 10-K for 2025, filed 2026-02-12
- 10-K for 2025, filed 2026-02-12
The filing itself
23.1%FCF margin
Free Cash Flow / Revenue x 100
Source
computed
Fiscal year
2025
Accession
0001093557-26-000027
Reported in
USD
- 10-K for 2025, filed 2026-02-12
- 10-K for 2025, filed 2026-02-12
The filing itself
n/aDebt/equity
We do not hold this figure for this company, so there is nothing to place.
Total Debt / Shareholders' Equity
Source
computed
Fiscal year
2025
Accession
0001093557-26-000027
Reported in
USD
- 10-K for 2025, filed 2026-02-12
- 10-Q for 2025, filed 2026-10-29
The filing itself
n/aDividend yield
We do not hold this figure for this company, so there is nothing to place.
Source
computed
Taken on
2026-11-07
Reported in
USD
- computed

Price is the furthest below its sector's middle: 0.16 against 0.37 on the market's range.

What it pays out: n/aWe do not hold this figure for this company, so there is nothing to place.

Five bars, one line

lens 7 of 9

1.99x

2.86x

3.51x

n/a

1.21x

SalesProfitFree cash flowDebtPrice

Each bar against this company's own average; the line is that average.

Filed2025

Market data2026-11-04

Each against its own average

4 of 5 read

Except where said otherwise: 10-K for 2025, filed 2026-02-12

Sales1.99x
Its own average over 10 years, 2.34B.
Profit2.86x
Its own average over 10 years, 292.0M.
Free cash flow3.51x
Its own average over 10 years, 307.1M.
Debtn/a
Its own average over 0 years.
Price1.21x
Its own average over 11 years, 73. Market data, 2026-11-04

Free cash flow is furthest from its own average, at 3.51 times.

The filed years, as a table

Each line is 100 at 2016-12-31, the first year we hold.

Filed year	Sales	Shares in issue
2016-12-31	100.0	n/a
2017-12-31	125.3	100.0
2018-12-31	179.9	102.2
2019-12-31	257.5	107.0
2020-12-31	336.1	121.8
2021-12-31	427.1	124.2
2022-12-31	507.6	123.8
2023-12-31	631.8	123.3
2024-12-31	703.5	119.6
2025-12-31	813.2	117.5

How sales was got

Source: filed
Statement: income
Fiscal year: 2025
Accession: 0001093557-26-000027
Reported in: USD

The filing itself

How shares in issue was got

Source: filed
Statement: income
Fiscal year: 2025
Accession: 0001093557-26-000027
Reported in: USD

The filing itself

Figures behind the shape

Growth

19.3%

faster is higher, placed against 4,950 companies as of 2026-11-07

Five-year revenue growth rate19.3%
Source
computed
Taken on
2026-11-07
Reported in
USD
- computed
Five-year EPS growth rate8.0%
Source
computed
Taken on
2026-11-07
Reported in
USD
- computed
One-year change in net income45.1%
Source
computed
Taken on
2026-11-07
Reported in
USD
- computed

Returns on capital

30.5%

higher is higher, placed against 5,089 companies as of 2026-11-07

Return on invested capitaln/a
We do not hold this figure for this company, so there is nothing to place.
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
Source
computed
Fiscal year
2025
Accession
0001093557-26-000027
Reported in
USD
- 10-K for 2025, filed 2026-02-12
- 10-K for 2025, filed 2026-02-12
- 10-K for 2025, filed 2026-02-12
- 10-Q for 2025, filed 2026-10-29
- 10-K for 2025, filed 2026-02-12
- 10-Q for 2025, filed 2026-10-29
The filing itself
Return on equity30.5%
Net Income / Shareholders' Equity x 100
Source
computed
Fiscal year
2025
Accession
0001093557-26-000027
Reported in
USD
- 10-K for 2025, filed 2026-02-12
- 10-Q for 2025, filed 2026-10-29
The filing itself
Return on assets13.2%
Net Income / Total Assets x 100
Source
computed
Fiscal year
2025
Accession
0001093557-26-000027
Reported in
USD
- 10-K for 2025, filed 2026-02-12
- 10-Q for 2025, filed 2026-10-29
The filing itself

Margins

60.1%

wider is higher, placed against 3,412 companies as of 2026-11-07

Gross margin60.1%
Gross Profit / Revenue x 100
Source
computed
Fiscal year
2025
Accession
0001093557-26-000027
Reported in
USD
- 10-K for 2025, filed 2026-02-12
- 10-K for 2025, filed 2026-02-12
The filing itself
Operating margin19.6%
Operating Income / Revenue x 100
Source
computed
Fiscal year
2025
Accession
0001093557-26-000027
Reported in
USD
- 10-K for 2025, filed 2026-02-12
- 10-K for 2025, filed 2026-02-12
The filing itself
Net margin17.9%
Net Income / Revenue x 100
Source
computed
Fiscal year
2025
Accession
0001093557-26-000027
Reported in
USD
- 10-K for 2025, filed 2026-02-12
- 10-K for 2025, filed 2026-02-12
The filing itself
Free cash flow margin23.1%
Free Cash Flow / Revenue x 100
Source
computed
Fiscal year
2025
Accession
0001093557-26-000027
Reported in
USD
- 10-K for 2025, filed 2026-02-12
- 10-K for 2025, filed 2026-02-12
The filing itself

Price

37.1x

cheaper is higher, placed against 4,362 companies as of 2026-11-07

Price to earnings37.1x
Price / Earnings per Share (diluted)
Source
computed
Fiscal year
2025
Accession
0001093557-26-000027
Reported in
USD
- computed
- 10-K for 2025, filed 2026-02-12
The filing itself
Price to book11.7x10-Q for 2025, filed 2026-10-29
Price / Book Value per Share, where BVPS = Shareholders' Equity / Diluted Shares
Source
computed
Fiscal year
2025
Accession
0001093557-26-000195
Reported in
USD
- computed
- 10-Q for 2025, filed 2026-10-29
- computed
- 10-K for 2025, filed 2026-02-12
The filing itself
EV to EBITDAn/a
We do not hold this figure for this company, so there is nothing to place.
Enterprise Value / EBITDA, where EV = Market Cap + Total Debt - Cash
Source
computed
Fiscal year
2025
Accession
0001093557-26-000027
Reported in
USD
- computed
- 10-K for 2025, filed 2026-02-12
- 10-K for 2025, filed 2026-02-12
- 10-Q for 2025, filed 2026-10-29
- 10-K for 2025, filed 2026-02-12
The filing itself
Price to sales ratio6.9x
Market Cap / Revenue, where Market Cap = Price x Diluted Shares
Source
computed
Fiscal year
2025
Accession
0001093557-26-000027
Reported in
USD
- computed
- 10-K for 2025, filed 2026-02-12
- 10-K for 2025, filed 2026-02-12
The filing itself

Safety

1.88

safer is higher, placed against 3,227 companies as of 2026-11-07

Debt to equityn/a
We do not hold this figure for this company, so there is nothing to place.
Total Debt / Shareholders' Equity
Source
computed
Fiscal year
2025
Accession
0001093557-26-000027
Reported in
USD
- 10-K for 2025, filed 2026-02-12
- 10-Q for 2025, filed 2026-10-29
The filing itself
Current ratio1.8810-Q for 2025, filed 2026-10-29
Current Assets / Current Liabilities
Source
computed
Fiscal year
2025
Accession
0001093557-26-000195
Reported in
USD
- 10-Q for 2025, filed 2026-10-29
- 10-Q for 2025, filed 2026-10-29
The filing itself
Interest coverage49.8x
Operating Income / Interest Expense
Source
computed
Fiscal year
2025
Accession
0001093557-26-000027
Reported in
USD
- 10-K for 2025, filed 2026-02-12
- 10-K for 2025, filed 2026-02-12
The filing itself
Altman Z-Score7.48
1.2 x A + 1.4 x B + 3.3 x C + 0.6 x D + 1.0 x E (A=WC/TA, B=RE/TA, C=EBIT/TA, D=MktCap/TL, E=Rev/TA)
Source
computed
Taken on
2026-11-07
Reported in
USD
- Computed from the 10-K for 2025, filed 2026-02-12
- Computed from the 10-K for 2025, filed 2026-02-12
- Computed from the 10-K for 2025, filed 2026-02-12
- Computed from the 10-K for 2025, filed 2026-02-12
- Computed from the 10-K for 2025, filed 2026-02-12

What it pays out

n/a

We do not hold this figure for this company, so there is nothing to place.

more, and better covered, is higher, with no cohort held

Dividend yieldn/a
We do not hold this figure for this company, so there is nothing to place.
Source
computed
Taken on
2026-11-07
Reported in
USD
- computed
Payout ration/a
We do not hold this figure for this company, so there is nothing to place.
Common Dividends Paid / Net Income x 100, both from the latest filed fiscal year
Source
computed
Fiscal year
2025
Accession
0001093557-26-000027
Reported in
USD
- 10-K for 2025, filed 2026-02-12
- Computed from the 10-K for 2025, filed 2026-02-12
- 10-K for 2025, filed 2026-02-12
The filing itself
Dividend cover ration/a
We do not hold this figure for this company, so there is nothing to place.
Source
computed
Taken on
2026-11-07
Reported in
USD
- computed

Share a finding

A link to the finding, not to you: it carries nothing about your account.